These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 8665346)
1. Disturbance of peripheral microvascular fluid permeability by the onset of atrioventricular asynchrony in patients with programmable pacemakers. Mahy IR; Lewis DM; Shore AC; Penney MD; Smith LD; Tooke JE Heart; 1996 May; 75(5):509-12. PubMed ID: 8665346 [TBL] [Abstract][Full Text] [Related]
2. Effect of dual chamber pacing on raised plasma atrial natriuretic peptide concentrations in complete atrioventricular block. Vardas PE; Travill CM; Williams TD; Ingram AM; Lightman SL; Sutton R Br Med J (Clin Res Ed); 1988 Jan; 296(6615):94. PubMed ID: 2962695 [No Abstract] [Full Text] [Related]
3. Correlation analysis of atrial natriuretic peptide concentration, echocardiographic left atrial and left ventricular dimensions, and renal function parameters in patients after permanent pacemaker implantation. Sielski J; Janion M; Gawor Z; Ciuraszkiewicz K; Sielska MR Cardiol J; 2009; 16(2):157-63. PubMed ID: 19387964 [TBL] [Abstract][Full Text] [Related]
4. Double blind crossover comparison of the effects of dual chamber pacing (DDD) and ventricular rate adaptive (VVIR) pacing on neuroendocrine variables, exercise performance, and symptoms in complete heart block. Oldroyd KG; Rae AP; Carter R; Wingate C; Cobbe SM Br Heart J; 1991 Apr; 65(4):188-93. PubMed ID: 1827588 [TBL] [Abstract][Full Text] [Related]
5. Effects of ventricular pacing on atrial natriuretic peptide levels during submaximal exercise in complete atrioventricular block. Wong CK; Lau CP; Cheng CH; Leung WH; Pun KK; Nicholls MG Am J Cardiol; 1990 Jun; 65(20):1400-1. PubMed ID: 2140490 [No Abstract] [Full Text] [Related]
6. Atrial natriuretic peptide for monitoring cardiovascular system performance following pacemaker implantation. Sielski J; Janion M; Gawor Z Kardiol Pol; 2005 Mar; 62(3):202-9; discussion 210. PubMed ID: 15830014 [TBL] [Abstract][Full Text] [Related]
7. Delayed decline in plasma atrial natriuretic peptide levels after an abrupt reduction in atrial pressures: observation in patients with dual-chamber pacing. Wong CK; Lau CP; Cheng CH; Leung WH; Pun KK; Nicholls MG Am Heart J; 1990 Oct; 120(4):882-5. PubMed ID: 2145733 [TBL] [Abstract][Full Text] [Related]
8. [Long-term effects of cardiac pacing on natriuretic atrial peptide levels in patients with AV block]. Cabello JB; Bordes P; Mauri M; Lozano MV; Herrero A Rev Esp Cardiol; 1990; 43 Suppl 2():13-9. PubMed ID: 2146721 [TBL] [Abstract][Full Text] [Related]
9. Twenty four hour variation in plasma atrial natriuretic factor during VVI and DDD pacing. Vardas PE; Markianos M; Skalidis E; Simantirakis E; Manios E; Papavasiliou E Heart; 1996 Jun; 75(6):620-2. PubMed ID: 8697168 [TBL] [Abstract][Full Text] [Related]
10. Effect of cilostazol on the ventricular escape rate and neurohumoral factors in patients with third-degree atrioventricular block. Kodama-Takahashi K; Kurata A; Ohshima K; Yamamoto K; Uemura S; Watanabe S; Iwata T Chest; 2003 Apr; 123(4):1161-9. PubMed ID: 12684307 [TBL] [Abstract][Full Text] [Related]
11. [Effect of AV synchronization and rate increase on hemodynamics and on atrial natriuretic peptide in patients with total AV block]. Lemke B; Gude J; von Dryander S; Barmeyer J; Braun BE; Krieg M Z Kardiol; 1990 Aug; 79(8):547-56. PubMed ID: 2145704 [TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide with artificial pacemakers. Nakaoka H; Kitahara Y; Imataka K; Fujii J; Ishibashi M; Yamaji T Am J Cardiol; 1987 Aug; 60(4):384-5. PubMed ID: 2956854 [No Abstract] [Full Text] [Related]
13. Effects of atrioventricular asynchrony on platelet activation: implication of thromboembolism in paced patients. Lau CP; Tse HF; Cheng G Heart; 1997 Oct; 78(4):358-63. PubMed ID: 9404251 [TBL] [Abstract][Full Text] [Related]
15. Effects of variation of atrioventricular interval on left ventricular diastolic filling dynamics and atrial natriuretic peptide levels in patients with DDD pacing for complete heart block. Styliadis IH; Gouzoumas NI; Karvounis HI; Papadopoulos CE; Efthimiadis GK; Karamouzis M; Parharidis GE; Louridas GE Europace; 2005 Nov; 7(6):576-83. PubMed ID: 16216760 [TBL] [Abstract][Full Text] [Related]
16. Does the mechanism of action of biatrial pacing for atrial fibrillation involve changes in cardiac haemodynamics? Assessment by Doppler echocardiography and natriuretic peptide measurements. Levy T; Jenkins GH; Walker S; Grieve L; Webb C; Buckley MG; Singer DR; Paul V Europace; 2000 Apr; 2(2):127-35. PubMed ID: 11225939 [TBL] [Abstract][Full Text] [Related]
17. [Modification of atrial natriuretic factor by the AV transmission time in pacemaker patients]. Noll B; Krappe J; Göke B Dtsch Med Wochenschr; 1988 Dec; 113(51-52):1994-6. PubMed ID: 2974414 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiological and haemodynamic basis for application of new pacemaker technology in sick sinus syndrome and atrioventricular block. Sutton R; Citron P Br Heart J; 1979 May; 41(5):600-12. PubMed ID: 465231 [TBL] [Abstract][Full Text] [Related]
19. [Secretion of atrial natriuretic peptide during artificial pacing: assessments including the influence of ventriculoatrial conduction]. Abe Y; Kadowaki K; Sato T; Nakagomi A; Kumagai T J Cardiol; 1992; 22(1):265-70. PubMed ID: 1307573 [TBL] [Abstract][Full Text] [Related]
20. Physiological importance of different atrioventricular intervals to improved exercise performance in patients with dual chamber pacemakers. Haskell RJ; French WJ Br Heart J; 1989 Jan; 61(1):46-51. PubMed ID: 2917098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]